Touchlight, a biotechnology company based in the UK, redeveloped and expanded its state-of-the-art DNA manufacturing facility located in London, UK, in May 2023.
The facility produces enzymatic DNA, from research to good manufacturing practice (GMP)-grade.
The expansion has tripled the DNA manufacturing capacity of the facility, surpassing more than 8kg of plasmid DNA in a year. The capacity exceeded the total global demand for plasmid DNA and can facilitate the commercialisation of genetic medicines.
No comments:
Post a Comment